Integrative Medicine in Childhood Cancer.
Elena J Ladas
https://pubmed.ncbi.nlm.nih.gov/30247963Actively Recruiting
All Genders
ID04495790
Advanced Integrative Oncology Treatment for Adult and Pediatric Patients With Cancer: A Prospective Outcomes Study
Led by Advanced Integrative Medical Science Institute · Updated on 2023-02-01
500
Participants Needed
1
Research Sites
293 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are studying patients with cancer who receive care at the AIMS Institute to understand disease-free survival in early stage cancer and three-year overall survival in advanced cancer. This observational study focuses on patients treated with Advanced Integrative Oncology (AIO), which combines naturopathic oncology care with conventional cancer treatments. The study aims to evaluate clinical outcomes associated with these integrative therapies, especially in both adult and pediatric cancer patients. Participants receive care that includes nutritional and botanical medicine integrated with their usual cancer treatments, provided by naturopathic doctors experienced in oncology. The study collects data prospectively in a consecutive case series format without altering participants' standard medical care. This approach helps answer whether exposure to AIO services improves clinical outcomes for cancer patients. Throughout the study, researchers collect medical records and treatment information to analyze survival outcomes over five years. Both adults and children with confirmed cancer diagnoses who consent to participate are followed to assess their disease progress and treatment effects. The study monitors survival and treatment correlations while participants continue their regular oncology care, with a planned follow-up lasting at least five years.
CONDITIONS
Brief Title
AIMS Cancer Outcomes Study
Who Can Participate
All Genders
Eligibility Criteria
You may qualify if you...
- New patient with a first office call or telemedicine consultation and a cancer diagnosis
- Established patient with a cancer diagnosis receiving treatment at the AIMS Institute
- Adults over 18 years who can understand the study and provide signed informed consent
- Children under 18 years who provide informed assent and have a parent or guardian who can consent
- Confirmed cancer diagnosis based on medical oncology records
You will not qualify if you...
- Patients without a cancer diagnosis
- Patients receiving care only via telehealth
- Unable to read or understand English well enough to consent and complete questionnaires
- Unwilling to participate in the AIMS Institute observational study
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or telemedicine consultation)
Long-term Monitoring
Duration - Up to 5 years
Participants are observed over time to assess survival and treatment outcomes related to integrative oncology care.
Periodic assessments throughout the study duration
Trial Site Locations
Total: 1 location
1
AIMS Institute
Seattle, Washington, United States, 98102
Actively Recruiting
Loading map...
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Published Research Related To This Trial
Use of alternative medicine by children with cancer in Washington state.
M L Neuhouser, R E Patterson, S M Schwartz...
https://pubmed.ncbi.nlm.nih.gov/11676573Complementary and alternative medicine practices, traditional healing practices, and cultural competency in pediatric oncology in Hawai' i.
Asad Ghiasuddin, Joyce Wong, Andrea M Siu
https://pubmed.ncbi.nlm.nih.gov/27641608Psychological side effects of breast cancer screening.
C Lerman, B Trock, B K Rimer...
https://pubmed.ncbi.nlm.nih.gov/1915212The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups.
C A McHorney, J E Ware, J F Lu...
https://pubmed.ncbi.nlm.nih.gov/8277801Melatonin as adjuvant cancer care with and without chemotherapy: a systematic review and meta-analysis of randomized trials.
Dugald Seely, Ping Wu, Heidi Fritz...
https://pubmed.ncbi.nlm.nih.gov/22019490High-dose parenteral ascorbate enhanced chemosensitivity of ovarian cancer and reduced toxicity of chemotherapy.
Yan Ma, Julia Chapman, Mark Levine...
https://pubmed.ncbi.nlm.nih.gov/24500406Colon cancer survival with herbal medicine and vitamins combined with standard therapy in a whole-systems approach: ten-year follow-up data analyzed with marginal structural models and propensity score methods.
Michael McCulloch, Michael Broffman, Mark van der Laan...
https://pubmed.ncbi.nlm.nih.gov/21964510Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity.
John P Pierce, Marcia L Stefanick, Shirley W Flatt...
https://pubmed.ncbi.nlm.nih.gov/17557947